Evaluating frailty in elderly patients undergoing heart procedures
Frailty Syndrome in Daily Practice of Interventional Cardiology Ward
Medical University of Silesia · NCT03209414
This study looks at how frailty affects the recovery and outcomes of heart procedures in older patients aged 65 and up with coronary artery disease.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 1000 (estimated) |
| Ages | 65 Years and up |
| Sex | All |
| Sponsor | Medical University of Silesia (other) |
| Locations | 1 site (Zabrze, Upper Silesia) |
| Trial ID | NCT03209414 on ClinicalTrials.gov |
What this trial studies
This observational study aims to assess the impact of frailty on the outcomes of invasive treatments for coronary artery disease in elderly patients aged 65 and older. It utilizes the Fried frailty scale and the instrumental activities of daily living (IADL) scale to evaluate patients admitted for symptomatic coronary artery disease, including stable and unstable conditions. The study will analyze the distribution of frailty scores before hospital discharge and investigate their prognostic significance regarding treatment results and complications. By understanding frailty in this context, the study seeks to improve treatment selection and follow-up care for these patients.
Who should consider this trial
Good fit: Ideal candidates for this study are patients aged 65 and older with symptomatic coronary artery disease.
Not a fit: Patients who are younger than 65 or those who do not provide informed consent will not benefit from this study.
Why it matters
Potential benefit: If successful, this study could enhance treatment decision-making and outcomes for frail elderly patients with coronary artery disease.
How similar studies have performed: While the specific approach of this study may be novel, similar studies have shown that assessing frailty can significantly impact treatment outcomes in elderly patients.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * aged ≥ 65 * symptomatic coronary artery disease A) stable B) unstable C) NSTEMI D) STEMI * written, informed consent Exclusion Criteria: * lack of consent
Where this trial is running
Zabrze, Upper Silesia
- II Dept. of Cardiology in Zabrze Medical University of Silesia — Zabrze, Upper Silesia, Poland (RECRUITING)
Study contacts
- Study coordinator: Andrzej R Tomasik, M.D. Ph.D., FESC
- Email: tomasik@poczta.onet.pl
- Phone: 0048323732372
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Frail Elderly Syndrome, Coronary Heart Disease, Acute Coronary Syndrome, Coronary Artery Bypass Grafting, Percutaneous Transluminal Coronary Angioplasty, Frailty syndrome, Coronary heart disease, Coronary revascularization